Jakub P. Jozwiak
Lawyers
Filters
Foley Trasimene Acquisition Corp. II $1.3 billion IPO
Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 130,000,000 units of Foley Trasimene Acquisition Corp. II for…
BioXcel Therapeutics $200 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000,000 shares of its common stock. The common stock is listed on the…